Walking Impairment
10
3
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
30%
3 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait After Spinal Cord Injury (SCI)
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients
Clinical Impacts of Structured Robotic Gait Training Programs
Investigating the Mechanisms of Welwalk Robot in Restoring Motor Function of the Lower Extremities in Stroke Patients
Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis
A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
Treadmill Training at Constant or Different Speeds for People With Traumatic Brain Injury
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment